cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Guardant Health Inc
27 own
8 watching
Current Price
$47.21
$-1.39
(-2.86%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,993.13M
52-Week High
52-Week High
49.86000
52-Week Low
52-Week Low
15.81000
Average Volume
Average Volume
1.71M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,993.13M
icon52-Week High49.86000
icon52-Week Low15.81000
iconAverage Volume1.71M
iconDividend Yield--
iconP/E Ratio--
What does the Guardant Health Inc do?
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.
Read More
How much money does Guardant Health Inc make?
News & Events about Guardant Health Inc.
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that it has been informed it will receive national reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW), effective July 24, 2023, for its Guardant360 CDx liquid biopsy test for...
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report additional data from its pivotal ECLIPSE study at Digestive Disease Week (DDW) on Tuesday, May 9, 2023. The company will host a webcast and conference call with primary investigators of the...
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, is pleased to announce that it will present data from two studies highlighting the performance of its blood-based screening technology to detect early-stage colorectal cancer (CRC), including the acceptance of the ECLIPSE...
Business Wire
1 year ago
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final module of its premarket approval (PMA) application for Shield, Guardant Healths blood test to screen for colorectal cancer (CRC...
Globe Newswire
1 year ago
Prospective screening of subjects for ESR1 mutations will use the Guardant360 CDx blood test for companion diagnostic developmentPhase 3 study is supported by previously presented ELAINE-1 and ELAINE-2 Phase 2 study resultsSermonix anticipates dosing the first patient in first half of 2023 COLUMBUS...
Frequently Asked Questions
Frequently Asked Questions
What is Guardant Health Inc share price today?
plus_minus_icon
Can Indians buy Guardant Health Inc shares?
plus_minus_icon
How can I buy Guardant Health Inc shares from India?
plus_minus_icon
Can Fractional shares of Guardant Health Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Guardant Health Inc stocks?
plus_minus_icon
What is today’s traded volume of Guardant Health Inc?
plus_minus_icon
What is today’s market capitalisation of Guardant Health Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Guardant Health Inc?
plus_minus_icon
What percentage is Guardant Health Inc down from its 52-Week High?
plus_minus_icon
What percentage is Guardant Health Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$47.21
$-1.39
(-2.86%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SOTERA HEALTH CO
SOTERA HEALTH CO
$13.65
$-0.04 (-0.29 %)
Castle Biosciences Inc
Castle Biosciences Inc
$26.44
$-0.06 (-0.23 %)
Ontrak Inc.
Ontrak Inc.
$1.72
$0.00 (0.00 %)
Exagen Inc
Exagen Inc
$4.00
$0.01 (0.25 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
SOTERA HEALTH CO
SOTERA HEALTH CO
$13.65
$-0.04 (-0.29 %)
Castle Biosciences Inc
Castle Biosciences Inc
$26.44
$-0.06 (-0.23 %)
Ontrak Inc.
Ontrak Inc.
$1.72
$0.00 (0.00 %)
Exagen Inc
Exagen Inc
$4.00
$0.01 (0.25 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00